PACB vs VREX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

PACB

48.3
AI Score
VS
VREX Wins

VREX

56.2
AI Score

Investment Advisor Scores

PACB

48score
Recommendation
HOLD

VREX

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PACB VREX Winner
Revenue 636.10M 116.75M VREX
Net Income 9.90M -90.86M VREX
Gross Margin 34.4% 33.4% VREX
Net Margin 1.6% -77.8% VREX
Operating Income 52.60M -89.97M VREX
ROE 2.0% 148.0% PACB
ROA 0.9% -12.6% VREX
Total Assets 1.10B 721.10M VREX
Cash 99.20M 55.91M VREX
Current Ratio 3.38 4.62 PACB
Free Cash Flow -22.50M -123.47M VREX

Relative Price Performance (Last 90 Days)

PACB 1M: +0.0% · 3M: +62.0% VREX 1M: -2.0% · 3M: -2.0%

Current Technical Phase

PACB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 43.1 · Price: $1.96

VREX

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope 0.5%) with fading momentum, RSI 33

RSI (14): 33.1 · Price: $18.10

Fundamentals Snapshot

Metric PACB VREX
Market Cap — —
Forward P/E -4.9 16.9
Trailing P/E — 34.3
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.3% 0.3%
Operating Margin -3.3% 0.1%
EPS -0.42 0.53
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, VREX is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.